THE ROLE OF ADIPONECTIN IN THE ATHEROSCLEROSIS DEVELOPMENT IN PATIENTS WITH STABLE ANGINA UND OBESITY

Authors

  • Habasonia T. N. Kharkiv National Medical University
  • Pashtiani R. V. Kharkiv National Medical University
  • Ryndina N. G. Kharkiv National Medical University
  • Dunaeva I. P. Kharkiv National Medical University

DOI:

https://doi.org/10.21856/j-PEP.2012.1.10

Keywords:

cardiovascular pathogology

Abstract

On today's day, cardiovascular pathogology remains a conductive cause of the disease and the death of the population. Despite significant progress in the scope of acute forms of its heart disease (ICS), associated with the introduction of invasive techniques, the propagation of stable angadia is reduced by I reaches 20% in the population of the elders over 65 years. Economic losses for a temporary disabled and premature death from cardio-vascular pathology in the past rated 2 billion hryvnias. The octrium of that significant economic expenses of the state are connected with the treatment and rehabilitation of this category of patients. In this regard, necessary subsequent research in the direction of determining the new links of the pathogenesis of the stable forms of ICS and the search for more effective treatment facilities

References

Бiловол, О. М. Основи дiагностики, лiкування та профiлактики основних кардiологiчних захворю-вань [Текст] / О. М. Бiловол, П. Г. Кравчун // Уч-бовий посiбник для студентiв V курсу медичних ВУЗiв IV рiвня акредитацiї. — Ч. 1. — Харкiв, ХН-МУ, 2009. — 402 с.

Сакалош, В.Ю. Першi пiдсумки всеукраїнського проекту для лiкарiв «Серцево-судинний ризик пiд контролем» [Текст] / В.Ю. Сакалош // Медiкс. Антиейджинг. — 2010. — № 2. — С. 40–42.

Heart Disease and Stroke Statistics — 2010 Update. A Report from the American Heart Association Statistics Committee and Stroke Statistics Subcommitee [Text] / D. Lloyd-Jones, R. J. Adams, T. M. Brown [et al.] // Circulation. — 2010. — Vol. 121. — P. 1–170.

Guidelines on the management of stable angina pectoris: executive summary. Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology; ESC Committee for Practice Guidelines [Text] / R. Fox, M. A. Garcia, D. Ardissino [et al.] // Europ. Heart. J. — 2006. — № 27 (11). — P. 1341–1381.

Calle, E. E. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms [Text] / E. E. Calle, R. Kaaks // Nature Rev. Cancer. — 2004. — Vol. 4. — P. 579–591.

Endothelial dysfunction in adiponectin deficiency and its mechanisms involved [Text] / Y. Cao, L. Tao, Y. Yuan [et al]. // J. Mol. Cell. Cardiol. — Vol. 46. — 2009. — P. 413–419.

Visfatin: a protein secreted by visceral fat that mimics the effects of insulin"[Text] / A. Fukuhara, M. Matsuda, M. Nishizawa [et al.] // Science. — 2005. — Vol. 307 — P. 426–30.

Rao, S. V. Obesity as a risk factor in coronary artery disease / S. V. Rao, M. Donahue, V. Fuster // Am. Heart. J. — 2001. — № 142. — P. 1002–1007.

Ковальова, О. М. Адипонектин та лептин як iн-сулiносенситайзери [Текст] / О. М. Ковальова, Т. В. Ащеулова, Т. М. Амбросова // Практична ангiологiя. — 2009, № 9–10. — С. 12–16.

Колберг, Б. Жировая ткань как эндокринный ор-ган [Текст] // Пробл. ендокрин. патол. — 2009. — № 1. — С. 38–44.

Чубриева, С.Ю. Жировая ткань как эндо-кринный регулятор [Текст] / С.Ю. Чубирева, Н. В. Глухов, А. М. Зайчик // Вестник Санкт-Пе-тербургского ун-та. — 2008. — Вып. 1. — С. 32–43.

Adiponectin stimulates production of nitric oxide in vascular endothelial cells [Text] / H. Chen, M. Montagnani, T. Funahashi [et al.] // J. Biol. Chem. — 2003. — Vol. 278. — P. 45021–45026.

Adiponectin decreases C-reactive protein synthesis from endothelial cells. Evidence for an adipose tissue-vascular loop [Text] / S. Devaraj, N. Torok, M. R. Dasu [et al.] // Arterioscler. Thromb. Vasc. Biol. — Vol. 28. — 2008. — P. 1368–1374.

Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice [Text] / J. Fruebis, T. S. Tsao, S. Javorschi [et al.] // Proc. Natl. Acad. Sci. USA. — 2001. — Vol. 98. — P. 2005–2010.

Косыгина, А. В. Новое в патогенезе ожирения: адипокины — гормоны жировой ткани [Текст] / А. В. Косыгина, О. В. Васюкова // Пробл. ен-докрин. патол. — 2009. — № 1. — С. 44–50.

cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose most abundant gene transcript 1) [Text] / K. Maeda, K. Okubo, I. Shimomura [et al.] // Biochem. Biophys. Res. Commun. — 1996. — Vol. 221, № 2. — P. 286–289.

Эндокринология [Текст] / Под ред. П. Н. Бодна-ра. — Винница: Нова книга, 2007. — 344 с.

Эндокринология [Текст] / Под. ред. И. И. Дедо-ва. — М.: Гэотар-Медиа, 2007. — 432 с.

Метаболический синдром [Текст] / Под ред. Г. Е. Ройтберга. — М.: Медпресс-информ., 2007. — 224 с.

Plasma adiponectin concentrations are associated with body composition and plant-based dietary factors in female twins [Text] / A. Cassidy, P. Skidmore, E. B. Rimm [et al.] // J. Nutr. — 2009. — Vol. 139, № 2. — P. 353–358.

Adiponectin is a better predictor of endothelial function of the coronary artery than HOMA-R, body mass index, immunoreactive insulin, or triglycerides [Text] / H. Okui, S. Hamasaki, S. Ishida [et al.] // Int. J. Cardiol. — 2008. — Vol. 126. — P. 53–61.

Oligomerization state-dependent activation of NF-kappa B signaling pathway by adipocyte complement-related protein of 30 kDa (Acrp30) [Text] / T. S. Tsao, H. E. Murrey, C. Hug [et al.] // J. Boil. Chem. — 2002. — Vol. 277. — P. 29359–29362.

Adglobular head domain of adiponectin increases fatty acid oxidation in newborn rabbit hearts [Text] / A. Onay-Besikci, J. Y. Altarejos, G. D. Lopaschuk // J. Biol. Chem. — 2004. — Vol. 279. — P. 44320– 44326.

Visfatin regulates genes related to lipid metabolism in porcine adipocytes [Text] / C. Yang, Lago [et al.] // J. Anim. Sci. — 2010. — Vol. 10. — P. 3233.

Visfatin and adipocytokine with proinflomatore and immunomodulatind properties [Text] / R. Alexander Moschen, Arthur Kasser [et al.] // J. Immunol. — 2007. — Vol. 178. — P. 1748.

Elevated plasma level of visfatin/pre-B cell colonyenhancing factor in patients with type 2 diabetes mellitus [Text] / Chen [et al.] // J. Clin. Endocrinol. Metabol. — 2006. — Vol. 91 (1). — P. 259.

Association of hypoadiponectinemia with coronary artery disease in men [Text] / M. Kumada, S. Kihara, S. Sumitsuji [et al.] // Arterioscler. Thromb. Vasc. Biol. — 2003. — Vol. 23. — P. 85–89.

Serum concentrations of adiponectin and risk of type 2 diabetes mellitus and coronary heart disease in apparently healthy middleaged men: results from the 18-year follow-up of a large cohort from southern Germany [Text] / W. Koenig, N. Khuseyinova, J. Baumert [et al.] // J. Am. Coll. Cardiol. — 2006. — Vol.48. — P. 1369–1377.

Adiponectin and coronary heart disease: a prospective study and metaanalysis / N. Sattar, G. Wannamethee, N. Sarwar [et al.] // Circulation. — 2006. — Vol. 114. — P. 623–629.

Low adiponectin levels are an independent predictor of mixed and noncalcified coronary atherosclerotic plaques [Text] / U. C. Broedl, C. Lebherz, M. Lehrke [et al.] // PLoS ONE. — 2009. — 4, № 3. — P. 4733.

Adiponectin is a negative regulator of NK cell cytotoxicity [Text] / K.-Y. Kim, J. K. Kim, S. H. Han [et al.] // J. Immunol. — 2006. — Vol. 176. — P. 5958–5964.

Иммунопатология атеросклероза. Значение био-логических маркеров в оценке кардиоваскуляр-ного риска [Текст] / В. А. Визир, А. Е. Березин // Укр. мед. часопис. — 2010. — № 2. — C. 23–36.

Association of adiponectin with coronary heart disease and mor tality: the Rancho Bernardo study [Text] / G. A. Laughlin, E. Barrett-Connor, S. May, C. Langenberg // Am. J. Epidemiol. — 2007. — Vol. 165, № 2. — P. 164–174.

Gaillard, S. A new program of therapeutic education for obese patients [Text] / S. Gaaliard, D. Galliard // Obesit. Metabol. — 2007. — Vol. 3. — P. 191– 205.

Impact of plasma adiponectin levels to the presence and severity of coronary artery disease in patients with metabolic syndrome [Text] / M. Selcuk, H. Selcuk, A. Temizhan [et al.] // Coron. Art. Dis. — 2008. — Vol. 19. — P. 79–84.

Ouchi, N. A Novel role for adiponectin in the regulation of inflammation [Text] / N. Ouchi, K. Walsh // Arterioscler. Thromb. Vasc. Biol. — 2008. — Vol. 28. — P. 1219–1221.

Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis [Text] / E. Brakenhielm, N. Veitonmaki, R. Cao [et al.] // Proc. Natl. Acad. Sci. USA. — 2004. — Vol. 101. — P. 2476–2481.

Exacerbation of heart failure in adiponectin-defi-cient mice due to impaired regulation of AMPK and glucose metabolism [Text] / Y. Liao, S. Takashima, N. Maed [et al.] // Cardiovasc. Res. — 2005. — Vol. 67. — P. 705–713.

Adiponectin-mediated modulation of hypertrophic signal in the heart [Text] / R. Shibata, N. Ouchi, M. Ito [et al.] // Nat. Med. — 2004. — Vol. 10. — P. 1384–1389.

Апанасенко, Г. Л. Первичная профилактика ише-мической болезни сердца в практике семейного врача [Text] / Г. Л. Апанасенко // Сiмейна ме-дицина: Науково-практичний журнал для лiкарiв загальної практики. — 2008. — № 4. — С. 53–59.

Rembold, H. Struktur und Synthese des neopterins [Text] / H. Rembold, L. Bushmann // Ann. Chem. — 1963. — Vol. 662. — P. 72–82.

Насонов, Е. Л. Неоптерин: новый иммунологиче-ский маркер аутоиммунных ревматических забо-леваний [Текст] / Е. Л. Насонов, М.Ю. Самсонов // Клинич. мед. — 2000. — № 48. — C. 43–46.

Histamine suppresses neopterin production in the human myelomonocytoma cell line THP [Text] / B. Widner, B. Wirleitner, G. Weiss, G. Fuchs // Arch. Immunol. Ther. Exp. — 2000 — Vol. 48. — P. 251–258.

Functional tetrahydrobiopterin synthesis in human platelets [Text] / N. Franscini, E. B. Bachli, N. Blau [et al.] // Circulation. — 2004. — Vol. 110. — P. 186–192.

Serum adiponectin levels are an independent predictor of the extent of coronary artery disease in men [Text] / M. Eynatten, J. G. Schneider, P. M. Humpert [et al.] // J. Am. Coll. Cardiol. — 2006. — Vol. 47. — P. 2124–2126.

Yansson, G. K. Inflamation, atherosclerosis and coronary artery disease [Text] / G. K. Yansson // N. Engl. J. Med. — 2005. — Vol. 352 (16). — P. 95.

Downloads

Published

2012-03-15

How to Cite

Habasonia, T. N., Pashtiani, R. V., Ryndina, N. G., & Dunaeva, I. P. (2012). THE ROLE OF ADIPONECTIN IN THE ATHEROSCLEROSIS DEVELOPMENT IN PATIENTS WITH STABLE ANGINA UND OBESITY. Problems of Endocrine Pathology, 39(1), 78-83. https://doi.org/10.21856/j-PEP.2012.1.10

Most read articles by the same author(s)

1 2 > >>